A drink containing a flower or herb flavor or a flower or herb flavor extract wherein the total sweetness of the drink at taking corresponds to 2.0% to 4.5% (inclusive) or 0.3% to 2.0% (inclusive) in terms of sucrose and the drink contains palatinose in such an amount as contributing to from 30% to 100% or from 20 to 100% of the total sweetness. This drink has a refreshing and light feel and a well-balanced taste.

Drink containing flower or herb flavor or flower or herb flavor extract

The present invention includes compositions and methods for preventing one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by an active agent or a drug in a human or animal subject comprising: an amount of a lysophosphatidyl compound adapted for oral administration effective to reduce or prevent one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by the active agent or drug. Such compositions may further comprise a monoglyceride, a free fatty acid or a combination of the foregoing, including, e.g., a eutectic mixture.

Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies

Liposomal formulations and polymer conjugates of curcumin, curcumin analogues and derivatives thereof for parenteral administration are disclosed herein. The formulations are effective in the treatment of progressive supranuclear palsy, Alzheimer's disease (AD), Parkinson's disease (PD), Tauopathies or stress disorders including Post Traumatic Stress Disorder (PTSD). Curcumin crosses the blood brain barrier, localizes in the hiTppocampus and striata, prevents stress-induced neuronal cell damage, and stimulates neurogenesis and remediation of damaged neural circuits.

Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders

Compositions and methods for the treatment of drug-induced long QT syndrome and other cardiac channelopathies are disclosed herein. The compositions and methods of the present invention comprise binding one or more QT prolonging drugs with a liposome prior to parenteral (intravenous or subcutaneous) administration, or administration of an empty liposome prior to or concomitantly with therapeutic agents known to have a high risk of QT prolongation, or immediately following an envenomation. The results presented show an abrogation of the adverse effects of QT prolonging drugs in a dose-dependent manner by the compositions of the present invention.

Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current

Compositions for preventing and/or treating oral diseases which contain at least one member selected from among vital lactic acid bacteria, materials containing the lactic acid bacteria, culture filtrate of the lactic acid bacteria and processed products thereof, together with at least one member selected from among xylitol, sorbitol, erythritol, trehalose, maltitol, mannitol, palatinose, reducing lactose, sucrose, fructose, glucose, fructooligosaccharide, aspartame, Acanthopanax senticosus extract, Houttuynia cordata extract, Monascus, turmeric pigment, Chaenomeles sinensis extract, ganoderma extract, crataegus extract, shiitake mushroom extract, alpinia extract, stevia extract, lotus germ extract, Momordicae fructus extract, green tea extract, milk thistle extract, purple unpolished rice extract, enzymatically digested licorice root, Engelhardtia chrysolepis Hance extract, ginkgo extract, rooibos tea extract, mugwort extract, glycyrrhizin, gymnema extract and Rosa roxburghii extract.

Compositions for preventing and/or treating oral diseases

PROBLEM TO BE SOLVED: To attain long time preservation and utilization rate improvement by surely suppressing the decomposition of curcuminoid through a safe means by keeping specified pH by letting adible aid coexist in curcuminoid in the state of aqueous solution. SOLUTION: The adible acid such as citric acid, malic acid, tartaric acid, lactic acid or phosphoric acid or/and its water-soluble acidic salt enough for turning the pH of acqueous solution to 5.5-2.5 is let coexist in the curcuminoid in the state of this acqueous solution so that a stabilized curcuminoid component useful for coloring, drink and food, medicine, cosmetics, articles outside medicine and feed or the like can be provided. COPYRIGHT: (C)1998,JPO

Method for stabilizing curcuminoid and stabilized curcuminoid compound

PROBLEM TO BE SOLVED: To provide a substance having high safety and capable of being a daily ingestible preventive for prostatic hypertrophy and to provide an ingesta containing the substance. SOLUTION: A curcuminoid such as curcumin, demethoxycurcumin or bisdemethoxycurcumin obtained from a plant of the family Zingiberaceae manifests an inhibiting action for testosterone-5α-reductase. This invention claims a utilization of the curcuminoid to prevention, remedy, etc., for prostatic hypertrophy.

Testosterone-5alpha-reductase inhibitor, preventive and remedy for prostatic hypertrophy and ingesta thereof

PROBLEM TO BE SOLVED: To provide a means for improving the gustatory flavor of extract from the flower part of basswood (e.g. Tilia cordata Mill. or Tilia platyphyllos Scop.) which is hard to be utilized because of having unpleasant gustatory flavor so as to make the flower part of basswood easily takable in the form of food and drink. SOLUTION: This means comprises the steps of mixing at least one kind of compound selected from the group consisting of sugar alcohols (e.g. erythritol, xylitol), citric acid, malic acid, lactic acid, phosphoric acid and monosaccharides wherein its sweetness is 0.1 to 0.7 time that of sucrose (e.g. glucose, xylose) and disaccharides (e.g. maltose, lactose) with an extract from the flower part of basswood.

Excellently gustatory extract composition derived from flower part of basswood

PROBLEM TO BE SOLVED: To obtain a lotus embryo extract composition capable of improving an unplatable taste such as bitterness or astringency possessed by the lotus embryo extract according to simple operations, excellent in economical efficiency and safety in production of a food and drink and utilizable in a wide field requiring the lotus embryo extract. SOLUTION: This lotus embryo extract composition comprises (A) at least one compound selected from sugar alcohols, edible acids and monosaccharides or disaccharides having a sweetness of 0.1-0.7 that of sucrose and (B) the lotus embryo extract and good in taste. The food and drink comprises the lotus embryo extract and the method for improving the taste of the lotus embryo extract is provided.

Lotus embryo extract composition, food and drink containing lotus embryo extract and method for improving taste of lotus embryo extract

PROBLEM TO BE SOLVED: To obtain the subject inhibitor that contains a glucosyltransferase- inhibitory substance extracted from jujube leaves as an active ingredient, can prevent the appearance of tooth decay with high safety and is useful as a oral cavity preparation and beverage or food product preventing tooth decay. SOLUTION: Leaves of jujube tree in Rhamnus japonica are extracted with a lower aliphatic alcohol, polyhydric alcohol, lower aliphatic ketone, water or its mixture to obtain a glucosyltransferase inhibitor and this substance is used as an active ingredient. In a preferred embodiment, this glucosyltransferase inhibitor is formulated to chewing gum in an amount of 0.1-1.0wt.%.

Riyouji Takagaki

Papers

Method for stabilizing curcuminoid and stabilized curcuminoid compound

Testosterone-5alpha-reductase inhibitor, preventive and remedy for prostatic hypertrophy and ingesta thereof

Excellently gustatory extract composition derived from flower part of basswood

Lotus embryo extract composition, food and drink containing lotus embryo extract and method for improving taste of lotus embryo extract

Glucosyltransferase inhibitor, oral cavity composition and food and beverage